Osaka, Japan

Yumena Nishida

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Senju USA, Inc.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yumena Nishida. Retrieved from https://idiyas.com/inventor/yumena-nishida

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yumena Nishida: Innovator in Aqueous Liquid Preparations

Introduction

Yumena Nishida is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of aqueous liquid preparations, particularly through his innovative patent. His work is characterized by a focus on enhancing the efficacy of pharmaceutical formulations.

Latest Patents

Yumena Nishida holds a patent for an aqueous liquid preparation that comprises arbekacin and/or a salt thereof, along with at least one water-soluble polymer. The polymers selected for this preparation include hydroxypropyl methylcellulose, hydroxyethyl cellulose, methyl cellulose, and polyvinylpyrrolidone. This invention aims to improve the delivery and effectiveness of arbekacin in medical applications.

Career Highlights

Nishida is currently employed at Senju USA, Inc., where he continues to develop innovative solutions in the pharmaceutical industry. His expertise in aqueous formulations has positioned him as a valuable asset to his team and the company.

Collaborations

Yumena Nishida collaborates with talented colleagues, including Yuki Nakamura and Tatsuya Sakai. Together, they work on advancing research and development in their field, contributing to the success of their projects.

Conclusion

Yumena Nishida's contributions to aqueous liquid preparations highlight his innovative spirit and dedication to improving pharmaceutical formulations. His work continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…